Klinik für Psychiatrie und Psychotherapie
  1. Startseite LMU Klinikum
  2. Psychiatrie und Psychotherapie
  3. Forschung/Research
  4. Supported Studies

Supported Studies

Supported by DFG - Deutsche Forschungsgemeinschaft

DFG Logo
DFG Logo

  • Enhancing educational and vocational recovery in adolescents and young adults with early psychosis through Supported Employment and Education (SEEearly)
  • Effects of early clozapine treatment on remission rates in acute schizophrenia (EARLY)
  • Insight into hippocampal neuroplasticity in schizophrenia by investigating molecular pathways during physical training (BrainTrain)
  • Multizentrische RCT-Psychotherapie-Vergleichsstudie: Cognitive Behavioral Analysis System of Psychotherapy (CBASP) vs. Behavioral Activation (BA) bei stationären Patienten mit persistierend depressiven und therapieresistenten Störungen (ChangePDD)
  • Mechanismus-basierte Anti-Aggression Psychotherapie: eine multizentrische, randomisierte, kontrollierte klinische Studie für Patientinnen und Patienten mit BPS (MAAP)
  • Effects of rTMS Compared to SSRI as Early Treatment of Depression (Early-TMS)

Supported by BMFTR (Bundesministerium für Forschung, Technologie und Raumfahrt; German Federal Ministry of Research, Technology and Space)

  BMFTR Logo

  • Treatment of major depressive disorder with bilateral theta burst stimulation: study protocol for a randomized, double-blind, placebo-controlled multicenter trial (TBS-D)
  • Early intervention with repetitive theta burst stimulation in adolescents and young adults with depressive disorders: a sequential Bayesian, randomized controlled pilot trial (EARLY-BURST)

Supported by ERA-NET NEURON

Logo Neuron
Logo Neuron

  • Examining the synergistic effects of a cognitive control videogame and self-administered non-invasive brain stimulation on alleviating depression (DiSCoVeR)

Supported by ERA PerMed

ERA PerMed Logo
ERA PerMed Logo

  • Validation of a Single-Subject Treatment Outcome Predictor for Repetitive Transcranial Magnetic Stimulation (rTMS) to Improve Negative Symptoms in Schizophrenia (PREMISS)
  • Effects of add‑on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame)

Supported by Horizon Europe

 Image ohne Titel

  • Naturalistische longitudinale Beobachtungsstudie bei Menschen mit Schizophrenie-Spektrum Störungen (CDP-STAR)

Supported by NIMH

 Image ohne Titel

  • The Psychosis-Risk Outcomes Network (ProNET)
  • International, multi-center collaboration (22 sites) to leverage existing MRI datasets to study the functional neurobiology of TS and comorbidities in primary (meta/mega-analysis) and secondary analyses. (ENIGMA-TS)